We are live on
!
Find out more
C
Chescapmanager Portfolio holdings
AUM
$1.17B
1-Year Est. Return
42.44%
This Fund
S&P 500
This Quarter
Est. Return
+12.58%
1 Year Est. Return
+42.44%
3 Year Est. Return
+202.08%
5 Year Est. Return
+174.76%
10 Year Est. Return
–
AUM
$680M
AUM Growth
-$22.8M
(-3.2%)
Cap. Flow
+$19.8M
Cap. Flow
% of AUM
2.92%
Top 10 Holdings %
Top 10 Hldgs %
66.57%
Holding
38
New
6
Increased
8
Reduced
4
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$20.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$19.5M |
| 3 |
Dollar Tree
DLTR
|
+$9.97M |
| 4 |
Theravance Biopharma
TBPH
|
+$6.83M |
| 5 |
DISH
DISH Network Corp.
DISH
|
+$3.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$28.4M |
| 2 |
Eagle Materials
EXP
|
+$10.2M |
| 3 |
PVT
Pivotal Acquisition Corp.
PVT
|
+$9.1M |
| 4 |
Cigna
CI
|
+$1.83M |
| 5 |
Newell Brands
NWL
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.86% |
| 2 | Miscellaneous | 26.78% |
| 3 | Consumer Discretionary | 20.12% |
| 4 | Industrials | 6.33% |
| 5 | Communication Services | 6% |
Similar funds
WP
TA
TWM
CF
KCM
TPI
ANBT
KBFS
Chescapmanager's Q4 2019 Portfolio in Review
As of Q4 2019, Chescapmanager held 38 positions worth $680M, down 3.2% from $703M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Chescapmanager's Q4 2019 filing shows 6 new, 8 increased, 4 reduced and 6 closed positions. Its largest new stake was Tiffany & Co.: 170,000 shares worth $22.7M. The largest sale was Celgene Corp, an estimated $28.4M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
- Chescapmanager's largest Q4 2019 buy was Tiffany & Co.: 170,000 shares worth $22.7M.
- Chescapmanager added most to Theravance Biopharma in Q4 2019, an estimated $6.83M increase.
- Chescapmanager's biggest Q4 2019 reduction was Eagle Materials, cutting an estimated $10.2M.
- Chescapmanager fully exited Celgene Corp in Q4 2019, selling an estimated $28.4M.
- Chescapmanager's ten largest holdings make up 67% of its $680M portfolio in Q4 2019.
- Chescapmanager opened 6 new positions and closed 6 in Q4 2019.
- Chescapmanager's portfolio value fell 3.2% quarter-over-quarter to $680M.
Based on Chescapmanager's 13F filing for Q4 2019, filed 12 Feb 2020.